ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Zymergen Inc

Zymergen Inc (ZY)

2.43
0.00
( 0.00% )
Updated: 11:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.43
Bid
2.30
Offer
2.31
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
2.43
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ZY Latest News

Ginkgo Bioworks Completes Acquisition of Zymergen

Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks...

Ginkgo to Acquire Zymergen

Ginkgo to Acquire Zymergen PR Newswire BOSTON and EMERYVILLE, Calif., July 25, 2022 Acquisition is expected to accelerate the development of Ginkgo's innovative horizontal synthetic biology...

Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€) today announced it has expanded its agreement with Octant to further scale their next-generation...

Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications

EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to...

Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€), today announced it has entered into an agreement with Octant for the sale of a modular...

Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)

- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...

Zymergen Reports Preliminary First Quarter 2022 Financial Results

EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€), today reported preliminary financial results for the first quarter ended...

Zymergen to Participate in the BofA Securities 2022 Healthcare Conference

EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€), today announced the company will be participating in the upcoming BofA Securities 2022...

Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022

EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€) today announced it will report preliminary financial results for the first quarter 2022 after...

Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results

EMERYVILLE, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (โ€œZymergenโ€ or the โ€œCompanyโ€), today reported preliminary financial results for the fourth quarter and...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ZY - Frequently Asked Questions (FAQ)

What is the current Zymergen share price?
The current share price of Zymergen is US$ 2.43
What is the 1 year trading range for Zymergen share price?
Zymergen has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLBXBlackBoxStocks Inc
US$ 4.83
(185.80%)
175.08M
STAIScanTech AI Systems Inc
US$ 2.24
(52.38%)
45.28M
IPAImmunoPrecise Antibodies Ltd
US$ 0.6801
(37.95%)
283.47M
ASSTAsset Entities Inc
US$ 1.24
(37.78%)
114.09M
REKRRekor Systems Inc
US$ 2.1181
(34.91%)
28.43M
STFSStar Fashion Culture Holdings Ltd
US$ 2.5509
(-81.12%)
28.29M
HEPAHepion Pharmaceuticals Inc
US$ 0.1299
(-59.63%)
27.7M
STBXStarBox Group Holdings Ltd
US$ 0.6451
(-33.94%)
1.26M
GODNGolden Star Acquisition Corporation
US$ 10.5753
(-33.86%)
29.81k
GODNUGolden Star Acquisition Corporation
US$ 11.72
(-33.03%)
8.36k
IPAImmunoPrecise Antibodies Ltd
US$ 0.6801
(37.95%)
283.47M
BLBXBlackBoxStocks Inc
US$ 4.83
(185.80%)
175.08M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.2875
(20.34%)
160.78M
NVDANVIDIA Corporation
US$ 147.485
(4.73%)
150.13M
RGTIRigetti Computing Inc
US$ 13.3281
(-4.66%)
126.91M

ZY Discussion

View Posts
janice shell janice shell 4 months ago
I know. I just posted to the last person who'd had something to say about this company.
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 4 months ago
My post date was 2022
๐Ÿ‘๏ธ0
janice shell janice shell 4 months ago
What date? The complaint was filed in federal court today.
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 4 months ago
Check that date
๐Ÿ‘๏ธ0
janice shell janice shell 4 months ago
fwiw:

SEC Charges Zymergen Inc. With Misleading IPO Investors About Companyโ€™s Market Potential and Sales Prospects

https://www.sec.gov/newsroom/press-releases/2024-129

The Complaint:

https://www.sec.gov/files/litigation/admin/2024/33-11303.pdf
๐Ÿ‘๏ธ0
Triple nickle Triple nickle 3 years ago
About time here
๐Ÿ‘๏ธ0
Wake Setter Wake Setter 3 years ago
Still a great opportunity here. Once all the law firms quit spamming the news wires for ZY and the company gives new guidance we could see some steps up.

$8.40 was a gift from God
๐Ÿ‘๏ธ0
$treet $inatra $treet $inatra 3 years ago
great pop and even greater upside for the longer term holders, congrats!
๐Ÿ‘๏ธ0
JstnDFW JstnDFW 3 years ago
Such a good buy this morning! Congrats to those that got in on early trading today.
๐Ÿ‘๏ธ0
$treet $inatra $treet $inatra 3 years ago
yep, looking great!! back to $35+
๐Ÿ‘๏ธ0
Roadtojourney Roadtojourney 3 years ago
Kathy wood bought 2.5 milly as well??
๐Ÿ‘๏ธ0
JstnDFW JstnDFW 3 years ago
Back to 20-30 dollar range here!
๐Ÿ‘๏ธ0
Wake Setter Wake Setter 3 years ago
ZY good chance for recovery here, great entry for synthetic bio industry. Dramatically oversold - over reaction.
๐Ÿ‘๏ธ0
ciciagt ciciagt 3 years ago
Yes, news is bad. Softbank and others canโ€™t be pleased. Issues with Hyaline, management shake up, and maybe โ€˜meagerโ€™ revenues in 2022. Pitiful.
๐Ÿ‘๏ธ0
conix conix 3 years ago
No revenues and no CEO.
๐Ÿ‘๏ธ0
ciciagt ciciagt 3 years ago
Yikesโ€ฆ.
๐Ÿ‘๏ธ0
Lowjack Lowjack 3 years ago
Did you at least get a chance to bend over first?

Holy CF!
๐Ÿ‘๏ธ0
ciciagt ciciagt 3 years ago
I own Zymergen and watching a SPAC dealโ€ฆSRNG and Gingko Bioworks.
https://www.forbes.com/sites/johncumbers/2020/06/25/if-biology-can-build-it-they-will-come-ginkgo-bioworks-is-laying-the-foundation-for-the-4-trillion-bioeconomy/?sh=1ca8193841e0
๐Ÿ‘๏ธ0
janeyH janeyH 3 years ago
this is in my biosynthetic basket
๐Ÿ‘๏ธ0
janeyH janeyH 3 years ago
'sup rt?
๐Ÿ‘๏ธ0
rtrstock rtrstock 4 years ago
I've decided to start focusing on trading Initial Offerings again, it seemed percentage gainwise, to be strategical. So this is my next play.
๐Ÿ‘๏ธ0